showed a trendP = .07
OS also showed a trend that favored BsAb exposure in the IPTW-adjusted model ( P = .07) but remained comparable across groups in the matched and unadjusted analyses.
OS also showed a trend that favored BsAb exposure in the IPTW-adjusted model ( P = .07) but remained comparable across groups in the matched and unadjusted analyses.
A nonsignificant trend toward improved OS was observed in the BsAb-exposed group in the IPTW model, but this was not confirmed in the PSM analysis.
The 2-year cumulative incidence of moderate-to-severe chronic GVHD was higher in the BsAb-exposed patients in the unadjusted analysis (21.7%; 95% CI, 10.3%-35.7% vs 7.0%; 95% CI, 3.1%-13.2%; P = .11), although the difference did not reach statistical significance ( Figure 2 C; Table 2 ).